Skip to content

Albemarle stock

ALBNYSE

Albemarle Corporation, Basic MaterialsISIN US0126531013

$95.97▲ $1.04 (+1.1%)Closing price of 11 Nov 2026

51Score 51 out of 100, Neutral

Turn on early warning

Price and trend

42 / 100

Price history

−7.6% in one year

The chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Below the 200-day line: the price is 35% below it.

Trend change

Since July 2026 the 50-day line has been below the 200-day line; the trend has turned down.

Momentum

Normal: the price is neither overheated nor sold off (RSI 56).

Distance to the high

The price is 55% below its 52-week high. Largest decline in 20 years: 84% (November 2022 to April 2025).

Chart figures for advanced users
SMA 50$105.19
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$146.54
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)56
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$90.19
The lowest closing price of the last twelve months.
Resistance$215.62
The highest closing price of the last twelve months.
Market cap
$11.33B
Div. yield
1.69%
12 months
22.1
includes one-off items, adjusted 11
10.4
on earnings for the next twelve months ($9.27 per share)
Fair value
$98.58

Snapshot

Computed from the data by fixed rules, no AI

  • Albemarle Corporation belongs to the Chemicals (Specialty) industry (United States) and, with a market value of $11.33B, is number 29 of 108 companies in its industry on MEQIRI.
  • In fiscal 2025 it reported revenue of $5.14B (down 4.4% year on year) and a loss of $510.63M.
  • For fiscal 2026, analysts expect on average revenue of $6.07B (up 17.9%) and adjusted earnings per share of $10.99.
Show more
  • MEQIRI Score 51 out of 100 (Neutral): rank 311 of 467 in Basic Materials, median 58.
  • Our model puts fair value at $98.58, with the price 3% below it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Reliable dividendNo dividend cut for over 32 years.
  • Earnings turn into cashFree cash flow 212% of earnings over the last 12 months.Fundamentals 59
  • Growing faster than its industryRevenue up 10.4% a year since 2020, Chemicals (Specialty) median 6%.Growth 60

Weaknesses

  • Margin fallingOperating margin 1.8%, average of the prior years 16% (to 2024).Profitability 47
  • Turned to a lossEarnings per share from $3.53 in 2020 to −$5.75.Growth 60
  • Analysts expect falling earningsDown 7.3% a year through 2028 (estimates from 10 analysts).Growth 60
51/ 100
MEQIRI Score
Neutral

The score is held back by technical analysis and momentum.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

The fundamentals are in the middle range.

Profit consistency80% of years
Cash conversion (free cash flow to earnings, 12 months)212%
ROIC (12 months)5.9%
Positive free cash flow30% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk high

How well MEQIRI warns

One of the 30% with the highest crash risk among smaller stocks.

From 2016 to 2025, 36 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What drives the risk

  • price far below its 52-week high
  • high price swings
  • cyclical sector (energy or materials), as a group, crashed more often in the backtest

Valuation

Valuation signal

Fairly valued
Price
$95.97
Fair value
$98.58
Gap to fair value
−3%

In our model the price counts as cheap below $70.41 and expensive above $164.30 (uncertainty high, based on the price swings of the past year).

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $81.34, at 7.8% it would be $124.47.

Valuation metrics

no data
8.3
Fair value (model)
$98.58

From the cash-flow model alone; the profit includes one-off items, so there is no industry value.

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

20 years

In the twelve months to 30 Sep 2026, revenue rose 24.4% on the twelve months before. Revenue has grown solidly since 2006, at about 4% per year.

Margins

20 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2025: gross 13%, operating 2%, net −10%. Last 12 months: net 11%.

Debt & balance sheet

latest quarter
0.17
−0.5x
2.34
Cash & equivalents
$1.85B

Debt is low, but interest coverage is weak. Keep an eye on the interest burden and refinancing.

Earnings

Next earnings
10 Feb 2027in 90 days
Last reported
4 Nov 2026EPS reported $2.58 (expected $2.53)in line with expectations

Analyst estimates

Analysts have cut their 2027 earnings estimate by 12.0% since 15 Oct 2026. Falling estimates often precede bad news.

Fiscal 202613 analysts
Earnings per share
$10.99−2.7%
Revenue
$6.07B−0.8%
Fiscal 202714 analysts
Earnings per share
$8.99−12.0%
Revenue
$6B−3.5%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook raised

Share price after the results: +10.3%

2026 outlook raised: net sales of $1.4 to $1.6 billion and adjusted EBITDA of $275 to $325 million; capex is reduced, while energy storage volumes are modestly lower due to a plant fire.

Supporting passage from the call, verbatim
“As a result, we are increasing our full year outlook ranges, raising net sales to $1.4 billion to $1.6 billion and adjusted EBITDA to $275 million to $325 million.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 6 Aug 2026 (fiscal Q2 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

No open-market purchases in the last 6 months. One insider sold, $3.01M in total.

Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.

  • Masters J KentSale

    15 May 2026, Chairman & CEO

    Shares
    16,393
    Price
    $183.72
    Value
    $3.01M

Partial trades from one filing are shown in one row, with the average price.

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Albemarle

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

467 rated companies in Basic Materials

Rank 311 of 467
311/ 467
This company
51
Sector median
58

Categories against the sector median

ProfitabilityMedian of 467 companies47 (median 49)2 below the median
GrowthMedian of 467 companies60 (median 54)6 above the median
FundamentalsMedian of 467 companies59 (median 65)6 below the median
ValuationMedian of 426 companies with a value66 (median 69)3 below the median
StabilityMedian of 467 companies56 (median 67)11 below the median
Capital allocationMedian of 467 companies44 (median 52)8 below the median
Technical analysisMedian of 467 companies42 (median 54)12 below the median
MomentumMedian of 467 companies33 (median 51)18 below the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Chemicals (Specialty)

The next larger and next smaller companies by market value

All 108 Chemicals (Specialty) stocks

ETFs that hold Albemarle

Held by 39 ETFs on Xetra. Shown per index: the ETF with the largest weight.

ETFWeightCostFund size
L&G Battery Value-Chain UCITS ETFBATE1.91%0.49%€668.78M
Amundi MSCI New Energy UCITS ETF DistLYM91.39%0.60%€956.11M
Amundi MSCI Smart Mobility UCITS ETF AccELCR1.07%0.45%€142.4M
Show 5 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 11 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 6 Nov 2026)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy